{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T11:18:23Z","timestamp":1753355903492},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.mehy.2004.06.031","type":"journal-article","created":{"date-parts":[[2004,10,14]],"date-time":"2004-10-14T15:19:00Z","timestamp":1097767140000},"page":"273-278","source":"Crossref","is-referenced-by-count":4,"title":["Lower expression of cyclooxygenase-2: is it associated with the development of borderline ovarian tumors?"],"prefix":"10.1016","volume":"64","author":[{"given":"Polat","family":"Dursun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat","family":"Gultekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunter","family":"Yuce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Ayhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2004.06.031_bib1","series-title":"Novak gynecology","first-page":"1245","article-title":"Ovarian cancer","author":"Berek","year":"2002"},{"key":"10.1016\/j.mehy.2004.06.031_bib2","unstructured":"Epithelial ovarian carcinoma. In Philip J. Disaia, William T Creasman, editors. Clinical gynecologic oncology. 6th ed., Mosby Inc, p. 289"},{"issue":"2002","key":"10.1016\/j.mehy.2004.06.031_bib3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/jsre.2002.6532","article-title":"Role of cyclooxygenase-2 in breast cancer","volume":"108","author":"Singh","year":"2002","journal-title":"Journal of Surgical Research"},{"key":"10.1016\/j.mehy.2004.06.031_bib4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/gyno.2002.6620","article-title":"Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2\/neu expression in ovarian cancer","volume":"85","author":"Ferrandina","year":"2002","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.mehy.2004.06.031_bib5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0090-8258(02)00066-5","article-title":"High cyclooxygenase-2 expression in cervical adenocarcinomas","volume":"88","author":"Chen","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.mehy.2004.06.031_bib6","first-page":"M69","article-title":"Cyclooxygenase-2 and carcinogenesis","volume":"1470","author":"Prescott","year":"2000","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.mehy.2004.06.031_bib7","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ygyno.2003.10.053","article-title":"Cyclooxygenase-1 and 2 in normal and malignant human ovarian epithelium","volume":"92","author":"Li","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.mehy.2004.06.031_bib8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1368-8375(03)00035-6","article-title":"Carcinogenesis and cyclooxygenase: the potential role of COX-2 inhibition in upper aerodigestive tract cancer","volume":"39","author":"Mohan","year":"2003","journal-title":"Oral Oncol"},{"issue":"3\u20135","key":"10.1016\/j.mehy.2004.06.031_bib9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0960-0760(03)00380-7","article-title":"Aromatase and cyclooxygenases: enzymes in breast cancer","volume":"86","author":"Brueggemeier","year":"2003","journal-title":"Steroid Biochem Mol Biol"},{"issue":"5","key":"10.1016\/j.mehy.2004.06.031_bib10","first-page":"1741","article-title":"Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival","volume":"9","author":"Miyata","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"9","key":"10.1016\/j.mehy.2004.06.031_bib11","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/nm0901-1041","article-title":"NSAIDs inhibit alpha V beta 3 integrin- mediated and Cdc42\/Rac-dependent endothelial-cell spreading, migration and angiogenesis","volume":"7","author":"Dormond","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.mehy.2004.06.031_bib12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1476-4598-2-10","article-title":"Lipoxygenase and cyclooxygenase metabolism: new insight in treatment and chemoprevention of pancreatic cancer","volume":"2","author":"Ding","year":"2003","journal-title":"Mol Cancer"},{"issue":"27","key":"10.1016\/j.mehy.2004.06.031_bib13","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2174\/1381612033454036","article-title":"COX-2 and colorectal cancer","volume":"9","author":"Ferrandez","year":"2003","journal-title":"Curr Pharm Des"},{"issue":"2","key":"10.1016\/j.mehy.2004.06.031_bib14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0094-0143(02)00178-7","article-title":"Chemoprevention of prostate cancer. Focus on key opportunities and clinical trials","volume":"30","author":"Leach","year":"2003","journal-title":"Urol Clin North Am"},{"issue":"4","key":"10.1016\/j.mehy.2004.06.031_bib15","first-page":"569","article-title":"An immunohistochemical study of cyclooxygenase (COX)-2 expression in endocrine tumors of the pancreas","volume":"21","author":"Okami","year":"2002","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.mehy.2004.06.031_bib16","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1034\/j.1600-0463.2003.1111001.x","article-title":"Cyclooxygenase-2 and gastric carcinogenesis","volume":"111","author":"Saukkonen","year":"2003","journal-title":"APMIS"},{"issue":"4","key":"10.1016\/j.mehy.2004.06.031_bib17","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0003-4975(03)00334-5","article-title":"Lung cancer and cyclooxygenase-2","volume":"76","author":"Castelao","year":"2003","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.mehy.2004.06.031_bib18","first-page":"99","article-title":"Expression of cyclooxygenase-2 and its relationship to p53 accumulation in ovarian adenocarcinomas","volume":"22","author":"Shigemasa","year":"2003","journal-title":"Int J Oncol"},{"issue":"2","key":"10.1016\/j.mehy.2004.06.031_bib19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/cncr.11064","article-title":"A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors","volume":"97","author":"Kmet","year":"2003","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.mehy.2004.06.031_bib20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/01.LAB.0000056994.81259.32","article-title":"RAS mutations in ovarian and extraovarian lesions of serous tumors of borderline malignancy","volume":"83","author":"Diebold","year":"2003","journal-title":"Lab Invest"},{"issue":"6","key":"10.1016\/j.mehy.2004.06.031_bib21","first-page":"2670","article-title":"K-Ras-mediated increase in cyclooxygenase 2 mRNA stability involves activation of the protein kinase B1","volume":"61","author":"Sheng","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.mehy.2004.06.031_bib22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0090-6980(02)00029-1","article-title":"Distinct functions of COX-1 and COX-2","volume":"68\u201369","author":"Morita","year":"2002","journal-title":"Prostaglandins Lipid Mediators"},{"issue":"3","key":"10.1016\/j.mehy.2004.06.031_bib23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S1071-5576(02)00141-7","article-title":"Effects of prostaglandin E(2) on proliferation and apoptosis of epithelial ovarian cancer cells","volume":"9","author":"Munkarah","year":"2002","journal-title":"J Soc Gynecol Investig"},{"issue":"2","key":"10.1016\/j.mehy.2004.06.031_bib24","first-page":"362","article-title":"Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells","volume":"58","author":"Sheng","year":"1998","journal-title":"Cancer Res"},{"issue":"52","key":"10.1016\/j.mehy.2004.06.031_bib25","doi-asserted-by":"crossref","first-page":"48997","DOI":"10.1074\/jbc.M107829200","article-title":"Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase\/Akt pathway","volume":"276","author":"Lin","year":"2001","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.mehy.2004.06.031_bib26","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/bjc.1995.523","article-title":"Prostaglandin E2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators","volume":"72","author":"Schrey","year":"1995","journal-title":"Br J Cancer"},{"issue":"10","key":"10.1016\/j.mehy.2004.06.031_bib27","first-page":"3232","article-title":"Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells","volume":"8","author":"Tong","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"17","key":"10.1016\/j.mehy.2004.06.031_bib28","first-page":"4903","article-title":"Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells","volume":"62","author":"Tang","year":"2002","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.mehy.2004.06.031_bib29","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/carcin\/22.9.1557","article-title":"Cyclooxygenase-2, malondialdehyde and pyrimidopurinone adducts of deoxyguanosine in human colon cells","volume":"22","author":"Sharma","year":"2001","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.mehy.2004.06.031_bib30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/carcin\/22.1.5","article-title":"Carcinogen substrate specificity of human COX-1 and COX-2","volume":"22","author":"Wiese","year":"2001","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.mehy.2004.06.031_bib31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1470-2045(00)00256-4","article-title":"Role of nitric oxide in carcinogenesis and tumour progression","volume":"2","author":"Lala","year":"2001","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.mehy.2004.06.031_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1139\/y02-007","article-title":"Role of nitric oxide in tumour progression with special reference to a murine breast cancer model","volume":"80","author":"Jadeski","year":"2002","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.mehy.2004.06.031_bib33","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/nm0901-1048","article-title":"Acceleration of intestinal polyposis through prostaglandin receptor EP2 in APC(Delta 716) knockout mice","volume":"7","author":"Sonoshita","year":"2001","journal-title":"Nat Med"},{"issue":"18","key":"10.1016\/j.mehy.2004.06.031_bib34","first-page":"4574","article-title":"Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis","volume":"59","author":"Daniel","year":"1999","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.mehy.2004.06.031_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1006\/excr.2001.5198","article-title":"Colocalization prostacyclin (PGI2) synthase\u2013caveolin-1 in endothelial cells and new roles for PGI2 in angiogenesis","volume":"266","author":"Spisni","year":"2001","journal-title":"Exp Cell Res"},{"issue":"1","key":"10.1016\/j.mehy.2004.06.031_bib36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/bbrc.1999.1840","article-title":"Thromboxane A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis","volume":"267","author":"Nie","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"issue":"23","key":"10.1016\/j.mehy.2004.06.031_bib37","doi-asserted-by":"crossref","first-page":"17397","DOI":"10.1016\/S0021-9258(19)85348-6","article-title":"Thromboxane A2 stimulates vascular smooth muscle hypertrophy by up-regulating the synthesis and release of endogenous basic fibroblast growth factor","volume":"268","author":"Ali","year":"1993","journal-title":"J Biol Chem"},{"issue":"4\u20135","key":"10.1016\/j.mehy.2004.06.031_bib38","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/08820139409066823","article-title":"The role of cytokines in the production of prostacyclin and thromboxane in human mononuclear cells","volume":"23","author":"Chen","year":"1994","journal-title":"Immunol Invest"},{"issue":"12","key":"10.1016\/j.mehy.2004.06.031_bib39","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/70995","article-title":"Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing","volume":"5","author":"Jones","year":"1999","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.mehy.2004.06.031_bib40","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s004280050467","article-title":"Serous tumors of low malignant potential of the ovary-molecular pathology: part 2","volume":"436","author":"Hauptmann","year":"2000","journal-title":"Virchows Arch"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987704004529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987704004529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T15:13:42Z","timestamp":1624720422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987704004529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0306987704004529"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2004.06.031","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}